MCK
Price
$668.58
Change
+$5.33 (+0.80%)
Updated
Aug 8 closing price
Capitalization
83.16B
87 days until earnings call
SNYR
Price
$3.54
Change
-$0.09 (-2.48%)
Updated
Aug 8 closing price
Capitalization
31.91M
Interact to see
Advertisement

MCK vs SNYR

Header iconMCK vs SNYR Comparison
Open Charts MCK vs SNYRBanner chart's image
McKesson
Price$668.58
Change+$5.33 (+0.80%)
Volume$1.3M
Capitalization83.16B
Synergy CHC
Price$3.54
Change-$0.09 (-2.48%)
Volume$25.23K
Capitalization31.91M
MCK vs SNYR Comparison Chart in %
Loading...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCK vs. SNYR commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCK is a Buy and SNYR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 10, 2025
Stock price -- (MCK: $668.58 vs. SNYR: $3.54)
Brand notoriety: MCK: Notable vs. SNYR: Not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MCK: 176% vs. SNYR: 32%
Market capitalization -- MCK: $83.16B vs. SNYR: $31.91M
MCK [@Medical Distributors] is valued at $83.16B. SNYR’s [@Medical Distributors] market capitalization is $31.91M. The market cap for tickers in the [@Medical Distributors] industry ranges from $83.16B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCK’s FA Score shows that 2 FA rating(s) are green whileSNYR’s FA Score has 1 green FA rating(s).

  • MCK’s FA Score: 2 green, 3 red.
  • SNYR’s FA Score: 1 green, 4 red.
According to our system of comparison, MCK is a better buy in the long-term than SNYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCK’s TA Score shows that 4 TA indicator(s) are bullish while SNYR’s TA Score has 3 bullish TA indicator(s).

  • MCK’s TA Score: 4 bullish, 6 bearish.
  • SNYR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MCK is a better buy in the short-term than SNYR.

Price Growth

MCK (@Medical Distributors) experienced а -4.32% price change this week, while SNYR (@Medical Distributors) price change was +5.36% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.77%. For the same industry, the average monthly price growth was +6.28%, and the average quarterly price growth was +0.62%.

Reported Earning Dates

MCK is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Distributors (+1.77% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCK($83.2B) has a higher market cap than SNYR($31.9M). MCK has higher P/E ratio than SNYR: MCK (26.78) vs SNYR (11.80). MCK YTD gains are higher at: 17.560 vs. SNYR (-19.545). MCK has higher annual earnings (EBITDA): 5.26B vs. SNYR (6.61M). MCK has more cash in the bank: 5.69B vs. SNYR (178K). SNYR has less debt than MCK: SNYR (28.1M) vs MCK (7.39B). MCK has higher revenues than SNYR: MCK (359B) vs SNYR (33.6M).
MCKSNYRMCK / SNYR
Capitalization83.2B31.9M260,815%
EBITDA5.26B6.61M79,600%
Gain YTD17.560-19.545-90%
P/E Ratio26.7811.80227%
Revenue359B33.6M1,068,452%
Total Cash5.69B178K3,197,191%
Total Debt7.39B28.1M26,299%
FUNDAMENTALS RATINGS
MCK vs SNYR: Fundamental Ratings
MCK
SNYR
OUTLOOK RATING
1..100
6785
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
769
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5934
P/E GROWTH RATING
1..100
3816
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCK's Valuation (13) in the Medical Distributors industry is somewhat better than the same rating for SNYR (61) in the null industry. This means that MCK’s stock grew somewhat faster than SNYR’s over the last 12 months.

MCK's Profit vs Risk Rating (7) in the Medical Distributors industry is somewhat better than the same rating for SNYR (69) in the null industry. This means that MCK’s stock grew somewhat faster than SNYR’s over the last 12 months.

MCK's SMR Rating (100) in the Medical Distributors industry is in the same range as SNYR (100) in the null industry. This means that MCK’s stock grew similarly to SNYR’s over the last 12 months.

SNYR's Price Growth Rating (34) in the null industry is in the same range as MCK (59) in the Medical Distributors industry. This means that SNYR’s stock grew similarly to MCK’s over the last 12 months.

SNYR's P/E Growth Rating (16) in the null industry is in the same range as MCK (38) in the Medical Distributors industry. This means that SNYR’s stock grew similarly to MCK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCKSNYR
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 6 days ago
38%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
38%
Bullish Trend 2 days ago
37%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
37%
Bullish Trend 2 days ago
34%
Advances
ODDS (%)
Bullish Trend 6 days ago
66%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
39%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
25%
Bullish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSPOU12.21N/A
N/A
Horizon Space Acquisition I Corp
ASR310.98-0.64
-0.21%
Grupo Aeroportuario del Sureste SA
PHUN2.58-0.06
-2.27%
Phunware
SKE15.33-0.41
-2.60%
Skeena Resources Limited
RXST7.19-0.60
-7.70%
RxSight

MCK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCK has been loosely correlated with COR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if MCK jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCK
1D Price
Change %
MCK100%
+0.80%
COR - MCK
64%
Loosely correlated
+2.42%
CAH - MCK
53%
Loosely correlated
+2.61%
SHTDF - MCK
9%
Poorly correlated
N/A
HSIC - MCK
6%
Poorly correlated
+0.06%
OMI - MCK
5%
Poorly correlated
+12.36%
More

SNYR and

Correlation & Price change

A.I.dvisor tells us that SNYR and ZYXI have been poorly correlated (+-1% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYR and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYR
1D Price
Change %
SNYR100%
-2.48%
ZYXI - SNYR
-1%
Poorly correlated
-1.36%
COSM - SNYR
-2%
Poorly correlated
-24.05%
CAH - SNYR
-3%
Poorly correlated
+2.61%
QIPT - SNYR
-5%
Poorly correlated
-5.33%
HSIC - SNYR
-7%
Poorly correlated
+0.06%
More